About Us
Legacy (Give Legacy, Inc.) makes sperm simple. We’re a US-based company offering at-home sperm testing and sperm freezing through mail-in kits, so you can check on your fertility or protect it for the future without ever stepping into a clinic.
We offer semen analysis, post-vasectomy testing, sperm DNA fragmentation testing and long-term sperm freezing (cryopreservation).
How it works: Order a kit online. It ships discreetly to your door. Collect your sample at home. On your schedule, in private. Ship it back. Your sample reaches our lab in 21 hours on average, about 30% faster than other mail-in providers. Faster arrival means a healthier sample and more accurate results. Your results arrive within 2 business days in a report reviewed by a physician, with practical tips for improving your sperm health. Legacy is available in all 50 states, starts at $145, and you can pay with your HSA or FSA.
Life doesn’t always go to plan, and your future family shouldn’t depend on timing. We store frozen sperm for up to 25 years. Legacy is the only company that splits your samples across multiple storage sites, so even if something goes wrong at one facility, your future is still safe.
Results you can trust, from home: Our mail-in kit is clinically validated: a 2025 study by our researchers, published in the American Journal of Men’s Health, showed that shipped samples accurately predict the results of a fresh sample. Sperm naturally slow down in transit, so our lab uses a predictive algorithm to adjust for it.We measure semen volume, sperm count, movement (motility) and shape (morphology) with computer-assisted semen analysis (CASA). For a deeper look, our sperm DNA fragmentation test checks the quality of the genetic material inside your sperm. It’s the only validated mail-in DNA fragmentation test in the US.
Every sample goes to our own andrology lab in Hoboken, New Jersey, which is CLIA-certified for high-complexity testing. We’re also approved by New York State for semen analysis and DNA fragmentation testing and licensed as a New York State tissue bank for sperm storage.
We started at Harvard in 2018, went through Y Combinator, and have raised over $50 million from investors including Justin Bieber. Along the way, Y Combinator named us a Top Company, Forbes named us one of America’s Best Startup Employers, the Financial Times ranked us among the fastest-growing companies, and Business Insider picked us as a startup likely to reach unicorn status.
We’d like you to meet our advisors—a group of international fertility and healthcare experts as passionate about parenthood as we are.

Dr. Turek is an internationally renowned expert in men’s sexual health and reproductive urology. Dr. Turek is fellowship trained and board certified by the American Board of Urology. He has received countless honors and awards for his work with male infertility and has provided valuable research to the men’s sexual health community.
Dr. Paul Turek has been recognized as one of America’s Best Doctors by seven accrediting organizations (US News and World Report Top Doctors, Marquis Who’s Who, Best Doctors, PatientsChoice.org, Top MD-Consumer’s Checkbook, SuperDoctors and Castle-Connolly Top Doctors). Dr. Turek graduated from Yale College with highest honors (summa cum laude), Phi Beta Kappa, and then attended medical school at Stanford University, where he also took top research honors. He completed his residency in urology at the Hospital of the University of Pennsylvania, the nation’s first medical school, founded by Benjamin Franklin.

The Honorable Dr. David J. Shulkin is a board-certified internist and widely respected healthcare executive who served as the ninth Secretary of the US Department of Veterans Affairs, where he was responsible for the nation’s largest integrated health care system. Secretary Shulkin has been named one of the Top 100 Physician Leaders of Hospitals and Health Systems by Becker’s Hospital Review and one of the “50 Most Influential Physician Executives in the Country” by Modern Healthcare and Modern Physician.
Prior to coming to VA, Secretary Shulkin held numerous physician leadership roles and academic positions. As an entrepreneur, Secretary Shulkin founded and served as the Chairman and CEO of DoctorQuality, one of the first consumer orientated sources of information for quality and safety in healthcare. Secretary Shulkin received his medical degree from the Medical College of Pennsylvania, completed his internship at Yale University School of Medicine and residency and fellowship in general medicine at the University of Pittsburgh Presbyterian Medical Center, and is the University of Pennsylvania Leonard Davis Institute Distinguished Health Policy Fellow.

Dr. Michael Eisenberg, M.D., is Associate Professor of Urology and, by courtesy, of Obstetrics and Gynecology at the University of Stanford Medical Center. Dr. Eisenberg specializes in men’s health, urology, sexual dysfunction, infertility, hypogonadism, and Peyronie’s Disease. He attended medical school at the Yale School Of Medicine Office of Student Affairs and is board-certified in urology.
Dr. Eisenberg’s research efforts include surgical innovation, epidemiologic studies, and basic science discoveries to improve the treatments, outcomes, and lives of infertile men.

Dr. Brian Levine, an award-winning board-certified reproductive endocrinologist and the founding partner and Practice Director of CCRM Fertility New York and the founder of Nodal, the online surrogacy platform.
Widely recognized as one the country’s leading fertility experts, Dr. Levine has been named a Castle Connolly Top Doctor since 2019 and has been interviewed by The New Yorker and CNN on the latest fertility science. He was awarded the highest prize by the American Society of Reproductive Medicine for an assisted reproductive technology (ART) video on three-dimensional sperm imaging techniques. Dr. Levine attended New York University School of Medicine, where he recently completed a term on NYU’s Board of Trustees.

Dr. Schlegel is an internationally recognized urologist who is recognized for providing the best medical care and achieving the best results possible for his patients. He has served as Chair of Urology at Cornell, where he developed a program that was recognized as being #5 in the country.
He is perhaps best recognized for developing the surgical procedure of microTESE, now recognized as the safest and most effective sperm retrieval treatment for non-obstructive azoospermia. His primary focus of activity is maintaining men’s health and treating severe male infertility and azoospermia.

Dr. Denny Sakkas is the Scientific Director at Boston IVF. He received his undergraduate training at the University of Melbourne, Australia and received his Doctorate of Philosophy at Monash University, Melbourne, Australia. His Ph.D. was performed at one of the leading Reproductive Research Units in the world, which was responsible for many of the innovations used in routine IVF today including, hormonal stimulation, embryo freezing, and micromanipulation.
He has previously held positions as Chief Scientific Officer at Molecular Biometrics Inc. and was an Associate Professor at the Department of Obstetrics, Gynecology and Reproductive Sciences at the Yale University School of Medicine, where he headed a successful Gamete Biology Research Team and served as the Director of Assisted Reproductive Treatment Laboratories of the Yale Fertility Center.

Dr. Francisco Arredondo is a respected and experienced clinician with over 20 years of experience in fertility care. Dr. Arredondo attended Medical School at Monterrey Institute of Technology and Higher Studies, where he graduated first in his class and earned the distinction as the Best Medical Student in the Nation.
He completed his Residency at the University of Texas Health Science Center in San Antonio and his Fellowship at the University of Pennsylvania. Dr. Arredondo is Board Certified in both Reproductive Endocrinology and Obstetrics and Gynecology. After his clinical training, he obtained a Masters in Healthcare Management at Harvard University, giving him an important new perspective on effective health care delivery.

Dr. Martin is a Resident Physician at Massachusetts General Hospital and Brigham and Women’s Hospital, where he is an emergency physician. He previously graduated with a dual degree from Harvard Medical School and Harvard Kennedy School.
Dr. Martin is the co-founder of Symbiosis A.I., a proprietary platform that leverages the power of machine learning and natural language processing to help providers optimize and automate their clinical documentation. He has received a number of awards for his studies and work including a full scholarship to study at the Harvard Kennedy School as a Dublin Fellow at the Center for Public Leadership.

Dr. Scott Lundy is Market Chief of Research and Consultant Staff Reproductive Urologist at Cleveland Clinic Abu Dhabi, UAE, and an Associate Professor at Cleveland Clinic Lerner College of Medicine of Case Western Reserve University. He earned his BS in Bioengineering from the University of Texas at Austin and MD/PhD degrees from the University of Washington, followed by urology residency and reproductive urology fellowship training at Cleveland Clinic. He is also a certified High Complexity Lab Director (HCLD).
Dr. Lundy leads a translational research program focused on male reproductive physiology, sperm’s role in early embryo development, and in vitro spermatogenesis. His research has secured millions of dollars in NIH and other extramural funding, and he has authored more than 100 peer-reviewed publications in journals including Nature Communications, European Urology, and Fertility & Sterility.

Dr. Tony Anderson brings more than 25 years of experience in embryology consulting and assisted reproductive technology. He is a founding partner of Pozitivf Fertility and the founder and CEO of IVF Academy USA, formerly EmbryoDirector, where he also serves as Dean of The Laboratory School.
Through his work across fertility care, laboratory education, and consulting, Dr. Anderson has helped advance practices in reproductive medicine. At Pozitivf Fertility, he is focused on applying Toyota Production System principles to fertility treatment, with the goal of streamlining operations, reducing costs, and making care more accessible to patients.
We are all someone’s legacy.
We’re a Harvard-backed group of experts who understand parenthood—and how much it matters.
The Legacy team brings international experience in sperm health, fertility, healthcare policy, and business with a world-class advisory board.




















